These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11149105)

  • 1. Sodium ferric gluconate therapy in renal transplant and renal failure patients.
    Yorgin PD; Belson A; Sarwal M; Alexander SR
    Pediatr Nephrol; 2000 Dec; 15(3-4):171-5. PubMed ID: 11149105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
    Nissenson AR; Lindsay RM; Swan S; Seligman P; Strobos J
    Am J Kidney Dis; 1999 Mar; 33(3):471-82. PubMed ID: 10070911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium ferric gluconate complex therapy in anemic children on hemodialysis.
    Warady BA; Zobrist RH; Wu J; Finan E;
    Pediatr Nephrol; 2005 Sep; 20(9):1320-7. PubMed ID: 15971073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
    Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
    Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of intravenous administration of Fe-gluconate-Na complex to maintain adequate body iron stores in hemodialysis patients.
    Navarro JF; Teruel JL; Liaño F; Marcén R; Ortuño J
    Am J Nephrol; 1996; 16(4):268-72. PubMed ID: 8739277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dosage pharmacokinetics of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
    Warady BA; Seligman PA; Dahl NV
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1140-6. PubMed ID: 17942782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.
    Faich G; Strobos J
    Am J Kidney Dis; 1999 Mar; 33(3):464-70. PubMed ID: 10070910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron supplementation in adolescent hemodialysis patients.
    Nailescu C; Castaneda M; Del Rio M; Flynn JT
    Clin Nephrol; 2004 Dec; 62(6):449-54. PubMed ID: 15630904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
    Michael B; Coyne DW; Fishbane S; Folkert V; Lynn R; Nissenson AR; Agarwal R; Eschbach JW; Fadem SZ; Trout JR; Strobos J; Warnock DG;
    Kidney Int; 2002 May; 61(5):1830-9. PubMed ID: 11967034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous intravenous sodium ferric gluconate improves efficacy in the maintenance phase of EPOrHu administration in hemodialysis patients.
    Bolaños L; Castro P; Falcón TG; Mouzo R; Varela JM
    Am J Nephrol; 2002; 22(1):67-72. PubMed ID: 11919405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
    Winkelmayer WC; Goldstein BA; Mitani AA; Ding VY; Airy M; Mandayam S; Chang TI; Brookhart MA; Fishbane S
    Am J Kidney Dis; 2017 Jun; 69(6):771-779. PubMed ID: 28063734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron management: innovative solutions to persistent challenges--focus on Ferrlecit.
    Vogel S; Schweitzer S; Seiler S
    ANNA J; 1999 Oct; 26(5):515-21. PubMed ID: 10776080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
    Folkert VW; Michael B; Agarwal R; Coyne DW; Dahl N; Myirski P; Warnock DG;
    Am J Kidney Dis; 2003 Mar; 41(3):651-7. PubMed ID: 12612989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium ferric gluconate for post-transplant anemia in pediatric and young adult renal transplant recipients.
    Gillespie RS; Symons JM
    Pediatr Transplant; 2005 Feb; 9(1):43-6. PubMed ID: 15667610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population.
    Coppol E; Shelly J; Cheng S; Kaakeh Y; Shepler B
    Ann Pharmacother; 2011 Feb; 45(2):241-7. PubMed ID: 21304025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
    Kaskel FJ
    Nat Clin Pract Nephrol; 2006 May; 2(5):244-5. PubMed ID: 16932433
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of ferumoxytol versus sodium ferric gluconate in anemia management in outpatient hemodialysis patients: A prospective cohort study.
    El Nekidy WS; El-Masri MM; Kadri A; Soong DC
    Clin Nephrol; 2021 Apr; 95(4):189-194. PubMed ID: 33433318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron indices after administration of sodium ferric gluconate complex in hemodialysis patients.
    Shalansky K; Hanko J; Pudek M; Li G; Jastrzebski J
    Am J Kidney Dis; 2011 Oct; 58(4):684-5. PubMed ID: 21840100
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.
    Brookhart MA; Freburger JK; Ellis AR; Winkelmayer WC; Wang L; Kshirsagar AV
    Am J Kidney Dis; 2016 Jan; 67(1):119-27. PubMed ID: 26385819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
    Nguyen TV
    Am J Health Syst Pharm; 2009 Jun; 66(12):1101-4. PubMed ID: 19498125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.